Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2010Clinical Lipidology

Lipid profile screening in second-generation antipsychotic users: the gap between policy and practice

View Full Paper
Ask AI
Bookmark
Share

Authors

EMElaine H. MorratoLoyola University ChicagoDHDaniel M. HartungOregon State University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Morrato et al. (2010) studied this question.

synapsesocial.com/papers/6a99e4816ce0f2d359b4f605https://doi.org/10.2217/clp.10.29
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme2008 · 76 citations
  2. 2An Assessment of the Independent Effects of Olanzapine and Risperidone Exposure on the Risk of Hyperlipidemia in Schizophrenic Patients2002 · 234 citations
  3. 3Prevalence of Baseline Serum Glucose and Lipid Testing in Users of Second-Generation Antipsychotic Drugs2008 · 104 citations
  4. 4Severe Mental Illness and Risk of Cardiovascular Disease2007 · 438 citations
  5. 5Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs2010 · 201 citations